Moore Capital Management’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $706K | Hold |
105,000
| – | – | 0.01% | 361 |
|
|
2025
Q1 | $949K | Hold |
105,000
| – | – | 0.02% | 275 |
|
|
2024
Q4 | $1.82M | Hold |
105,000
| – | – | 0.02% | 260 |
|
|
2024
Q3 | $1.68M | Hold |
105,000
| – | – | 0.03% | 260 |
|
|
2024
Q2 | $1.5M | Hold |
105,000
| – | – | 0.03% | 254 |
|
|
2024
Q1 | $1.49M | Hold |
105,000
| – | – | 0.02% | 235 |
|
|
2023
Q4 | $1.58M | Hold |
105,000
| – | – | 0.03% | 218 |
|
|
2023
Q3 | $1.66M | Hold |
105,000
| – | – | 0.03% | 214 |
|
|
2023
Q2 | $1.59M | Hold |
105,000
| – | – | 0.03% | 240 |
|
|
2023
Q1 | $1.52M | Hold |
105,000
| – | – | 0.03% | 239 |
|
|
2022
Q4 | $1.42M | Hold |
105,000
| – | – | 0.03% | 292 |
|
|
2022
Q3 | $1.66M | Hold |
105,000
| – | – | 0.04% | 360 |
|
|
2022
Q2 | $1.28M | Hold |
105,000
| – | – | 0.03% | 359 |
|
|
2022
Q1 | $986K | Hold |
105,000
| – | – | 0.03% | 405 |
|
|
2021
Q4 | $1.8M | Buy |
+105,000
| New | +$1.8M | 0.04% | 401 |
|